fda warning letters compounded semaglutide 2024 2025 Troubling Findings in Study of GLP-1 Compounders FDA warns telehealth providers over

The agency had received reports of patients administering 5 to 20 times more than the intended dose in some cases because they were unfamiliar with converting between milligrams, milliliters, and units. In one reported case, a patient struggled to obtain dosing instructions from a telehealth provider and resorted to online searches, ultimately taking five times the intended dose

Patients are trained to perform these injections at home

FAQ Q1: Can you take MOTS-c with retatrutide

It captures demographics, a prior-GLP-1 overlap yes/no, BMI, medication choice, additive preference, and shipping information and then closes with a Review-and-Pay screen